Class summary at a glance.

Every drug in the Allylamine Antifungal class tracked across NADAC, Part D Formulary, Part D Spending, FDA Orange Book, and shortage data. Ranked below by CY24 Part D spend. Click any molecule for the full drug profile.

Molecules in class: 1tracked in Part D
CY24 Part D spend: $15.3Mcombined across class
Total Rx claims: 1.2M721K unique beneficiaries
Generic mfrs (active): 7across all molecules

Every drug in this class, ranked by Part D spend.

CY2024 dataCMS Part D Spending Dashboard

Terbinafine

Brand: Terbinafine · 1.2M Part D claims (CY24) · 721K beneficiaries · First FDA approval: 2007-07-02

7 generic mfrs 52 plans require PA

Low NADAC$0.145

→

Avg plan cost$0.145

Part D spend $15.3M 1× spread, current vs floor

Class share

100%

of class CY24 spend

View profile →

Class summary at a glance.

Every drug in this class, ranked by Part D spend.

Related questions.